Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004650269 | SCV005145878 | uncertain significance | not specified | 2024-04-20 | criteria provided, single submitter | clinical testing | The c.1802G>T (p.R601L) alteration is located in exon 4 (coding exon 4) of the NPC1L1 gene. This alteration results from a G to T substitution at nucleotide position 1802, causing the arginine (R) at amino acid position 601 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |